DK158541C - Orale mopidamolformer og fremgangsmaade til deres fremstilling - Google Patents

Orale mopidamolformer og fremgangsmaade til deres fremstilling

Info

Publication number
DK158541C
DK158541C DK460683A DK460683A DK158541C DK 158541 C DK158541 C DK 158541C DK 460683 A DK460683 A DK 460683A DK 460683 A DK460683 A DK 460683A DK 158541 C DK158541 C DK 158541C
Authority
DK
Denmark
Prior art keywords
acid
mopidamol
addition salt
oral
procedures
Prior art date
Application number
DK460683A
Other languages
Danish (da)
English (en)
Other versions
DK460683D0 (da
DK460683A (da
DK158541B (da
Inventor
Gottfried Schepky
Rolf Brickl
Peter Gruber
Jochen Schmid
Ursula Springmeier
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK460683D0 publication Critical patent/DK460683D0/da
Publication of DK460683A publication Critical patent/DK460683A/da
Publication of DK158541B publication Critical patent/DK158541B/da
Application granted granted Critical
Publication of DK158541C publication Critical patent/DK158541C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
DK460683A 1982-10-09 1983-10-06 Orale mopidamolformer og fremgangsmaade til deres fremstilling DK158541C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823237575 DE3237575A1 (de) 1982-10-09 1982-10-09 Neue orale mopidamolformen
DE3237575 1982-10-09

Publications (4)

Publication Number Publication Date
DK460683D0 DK460683D0 (da) 1983-10-06
DK460683A DK460683A (da) 1984-04-10
DK158541B DK158541B (da) 1990-06-05
DK158541C true DK158541C (da) 1990-11-05

Family

ID=6175408

Family Applications (1)

Application Number Title Priority Date Filing Date
DK460683A DK158541C (da) 1982-10-09 1983-10-06 Orale mopidamolformer og fremgangsmaade til deres fremstilling

Country Status (18)

Country Link
US (2) US4596705A (fr)
EP (1) EP0108898B1 (fr)
JP (1) JPH07558B2 (fr)
AT (1) ATE21481T1 (fr)
AU (1) AU560251B2 (fr)
CA (1) CA1228546A (fr)
DE (2) DE3237575A1 (fr)
DK (1) DK158541C (fr)
ES (1) ES526331A0 (fr)
FI (1) FI79650C (fr)
GB (1) GB2128088B (fr)
GR (1) GR79015B (fr)
IE (1) IE56058B1 (fr)
IL (1) IL69930A (fr)
NO (1) NO833638L (fr)
NZ (1) NZ205894A (fr)
PT (1) PT77467B (fr)
ZA (1) ZA837499B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CA1323833C (fr) * 1987-04-28 1993-11-02 Yatindra M. Joshi Compositions pharmaceutiques sous forme de granules et methode de fabrication
US5364646A (en) * 1990-01-10 1994-11-15 Dr. Karl Thomae Gmbh Oral pharmaceutical forms of pimobendan
CA2039742A1 (fr) * 1990-04-23 1991-10-24 Andrew B. Dennis Comprimes pour ingredients pharmaceutiques sujets a problemes : composition et mode de preparation
US5156845A (en) * 1990-05-04 1992-10-20 Colgate-Palmolive Company Dry mouth lozenge
US5523289A (en) * 1991-04-15 1996-06-04 Abbott Laboratories Pharmaceutical composition
JP3426230B2 (ja) * 1991-05-20 2003-07-14 アベンティス・ファーマスーティカルズ・インコーポレイテッド 複数層の制御放出処方剤
EP1093814A1 (fr) * 1999-10-22 2001-04-25 Boehringer Ingelheim Pharma KG Utilisation du dipyridamole ou du mopidamol dans la fabrication d'un médicament pour le traitement et la prévention des troubles de la microcirculation dépendants de la fibrine
WO2001064182A2 (fr) * 2000-02-28 2001-09-07 Vectura Limited Ameliorations apportees a l'administration de medicaments par voie orale
US7064130B2 (en) * 2001-04-20 2006-06-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
AU2002350719A1 (en) * 2002-11-29 2004-06-23 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
EP1594503A2 (fr) * 2003-02-07 2005-11-16 Boehringer Ingelheim International GmbH Utilisation du dipyridamole ou mopidamole pour le traitement et la prevention de troubles dependant de mmp-9
BRPI0409796A (pt) 2003-04-24 2006-05-30 Boehringer Ingelheim Int uso de dipiridamol ou mopidamol para tratamento e prevenção de doenças tromboembolìticas e distúrbios provocados pela formação excessiva de trombina e/ou pela expressão elevada de receptores de trombina
US8709476B2 (en) * 2003-11-04 2014-04-29 Supernus Pharmaceuticals, Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
DK2210605T3 (en) * 2003-11-04 2017-05-22 Tcd Royalty Sub Llc Daily single dose doses of trospium.
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (fr) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Utilisation des inhibiteurs de PDE III pour la réduction de la taille du coeur chez des mammifères souffrant d'insufficances cardiaques
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
US9205054B2 (en) 2005-03-22 2015-12-08 Losan Pharma Gmbh Solubilized ibuprofen
SI1915137T1 (sl) * 2005-08-10 2013-12-31 Add Advanced Drug Delivery Technologies, Ltd. Pripravek z nadzorovanim sproščanjem za peroralno dajanje
CN101410094B (zh) * 2006-01-27 2013-04-17 阿普塔利斯制药股份有限公司 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统
WO2007090091A2 (fr) * 2006-01-27 2007-08-09 Eurand, Inc. Système d'administration de médicaments comprenant des médicaments faiblement basiques et des acides organiques
US7731604B2 (en) * 2006-10-31 2010-06-08 Taylor Made Golf Company, Inc. Golf club iron head
EP1920785A1 (fr) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Préparation liquide contenant un complexe du pimobendane et de la cyclodextrine
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
US8664252B2 (en) 2008-11-25 2014-03-04 Boehringer Ingelheim Vetmedica Gmbh Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
EP2825159B1 (fr) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Formulation de comprimé pharmaceutique pour le secteur médical vétérinaire, son procédé de production et d'utilisation
BR112015005489B1 (pt) * 2012-09-19 2022-07-12 Taiho Pharmaceutical Co., Ltd. Composição farmacêutica para administração oral com dissolução e/ou absorção aperfeiçoadas
MX2016000727A (es) 2013-07-19 2016-04-13 Boehringer Ingelheim Vetmed Composicion farmaceutica acuosa liquida que contiene derivados de ciclodextrina eterificada con conservante.
HUE056143T2 (hu) 2013-12-04 2024-01-28 Boehringer Ingelheim Vetmedica Gmbh Pimobendán javított gyógyászati készítményei
JP6525897B2 (ja) * 2016-01-21 2019-06-05 日清オイリオグループ株式会社 タブレットの硬度調整剤
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN109942445A (zh) * 2019-02-26 2019-06-28 山东瑞弘生物科技有限公司 甜菜碱盐酸盐合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322755A (en) 1964-03-10 1967-05-30 Boehringer Sohn Ingelheim Basic-substituted 1, 2, 3, 4-tetrahydropyrimido [5, 4-d]-pyrimidines
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
EP0019586A1 (fr) * 1979-05-11 1980-11-26 Ciba-Geigy Ag Mélanges antithrombotiques
DE2931573A1 (de) * 1979-08-03 1981-02-26 Thomae Gmbh Dr K Mittel zur bekaempfung des wachstums von krebszellen und dessen herstellung
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen

Also Published As

Publication number Publication date
IE56058B1 (en) 1991-04-10
DK460683D0 (da) 1983-10-06
PT77467B (de) 1986-05-07
US4650664A (en) 1987-03-17
ES8500743A1 (es) 1984-11-01
GB8326877D0 (en) 1983-11-09
DK460683A (da) 1984-04-10
NZ205894A (en) 1986-08-08
GB2128088B (en) 1986-04-30
ES526331A0 (es) 1984-11-01
EP0108898A1 (fr) 1984-05-23
NO833638L (no) 1984-04-10
DE3237575A1 (de) 1984-04-12
GB2128088A (en) 1984-04-26
EP0108898B1 (fr) 1986-08-20
CA1228546A (fr) 1987-10-27
IL69930A0 (en) 1984-01-31
DE3365465D1 (en) 1986-09-25
FI833605A (fi) 1984-04-10
FI79650C (fi) 1990-02-12
GR79015B (fr) 1984-10-02
ATE21481T1 (de) 1986-09-15
PT77467A (de) 1983-11-01
AU560251B2 (en) 1987-04-02
FI833605A0 (fi) 1983-10-05
FI79650B (fi) 1989-10-31
US4596705A (en) 1986-06-24
ZA837499B (en) 1985-06-26
IE832358L (en) 1984-04-09
JPH07558B2 (ja) 1995-01-11
IL69930A (en) 1986-08-31
DK158541B (da) 1990-06-05
JPS5989615A (ja) 1984-05-23
AU1998583A (en) 1984-04-12

Similar Documents

Publication Publication Date Title
DK158541C (da) Orale mopidamolformer og fremgangsmaade til deres fremstilling
ES8304797A1 (es) "procedimiento para la preparacion de nuevas formas orales de dipiridamol, en forma de granulados, pastillas o tabletas".
DE69009684D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
ATE170077T1 (de) Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'- halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff
FI945839A (fi) Bentsotiofeeniyhdisteiden ja vesiliukoisten syklodekstriinien inkluusiokompleksien vesipitoinen liuos ja niiden farmaseuttiset formulaatiot sekä menetelmä
IL65137A (en) (hetero)aroylimidazolones and pharmaceutical compositions containing them
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
DK241287A (da) Anvendelse af glutamin til fremstilling af et laegemiddel til behandling af kataboliske forstyrrelser
ES8609312A1 (es) Procedimiento para la preparacion de silibinina exenta de isosilibina
EP0037488A3 (en) Pharmaceutical composition for healing inflammatory and/or degenerative and/or atrophic mucous membranes
JPS57122085A (en) Circulatory disease extirpenter and use
IL133172A (en) Diphosphonic acid salts for the treatment of osteoporosis
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
SE8303886L (sv) Synergetisk antihypertensiv farmaceutisk komposition
DK32893A (da) Geminale cycloalkyldiphosphonsyrer og farmaceutisk acceptable salte heraf samt farmaceutisk sammensaetning omfattende samme
DE3160018D1 (en) Use of s-benzyl-3-benzylthiopropionthioate in pharmaceutical compositions
RU98114982A (ru) Состав, содержащий диосгенин
IT8321031A0 (it) Loro derivati, aventi attivita'sali di calcio di amminoacidi o di terapeutica, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
IT8819401A0 (it) Composizioni aminoacidiche perfezionate per il trattamento specifico delle insufficienze epatiche.
KR970702034A (ko) 과도한 산 분비와 관련된 경미한 위장관 질환의 치료를 위한 저용량 라니티딘 조성물(Low Dosage Ranitidine Compositions for the Treatment of Minor Gastrointestinal Disorders Associated with Excess Acid Secretion)

Legal Events

Date Code Title Description
PBP Patent lapsed